Delivery Order SPE2DB22D2006-SPE2DB24FV5UL
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract is for the delivery of Dupixent 300 mg/2 ml pens, a specialty pharmaceutical product, with a ceiling value of $7,456.75 and a completion date of December...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,709.46, is for the supply of Dupixent 300 mg/2 ml pens, a medication used to treat certain medical conditions. The award is not set-aside and has an ultimate completion date of May 1, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml pens. The delivery order has a firm fixed price of $5,711.17 and a completion date of October 25, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Dupixent 300 mg/2 ml pens, with a ceiling value of $18,122.85 and a completion date of June 25, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $13,720.20 firm fixed-price delivery order contract is for the supply of Dupixent 300 mg/2 ml pens. The contract has an ultimate completion date of May 21, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA). The $6,683.11 firm-fixed-price delivery order is for Dupixent 300 mg/2 ml pens, with a completion date of March 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml pens. The $12,946.16 firm fixed-price contract has a completion date of November 14, 2022 and was awarded on November 10, 2022. This award is associated with Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $27,751.10 delivery order contract is for the supply of the pharmaceutical product Dupixent 300 mg/2 ml pen, with a performance period through May 7, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $16,689.06 delivery order contract is for the supply of Dupixent 300 mg/2 ml pens. The contract is a firm-fixed price delivery order, with a period of performance through April 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Dupixent 300 mg/2 ml pens. The award has a ceiling value of $6,837.84 and a completion date of February 4, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive...
- SPE2DB22D2006Indefinite Delivery Contract
- SPE2DB22D2006-SPE2DB24FV5ULDelivery Order
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Dupixent 300 mg/2 ml pens. The single-award Indefinite Delivery Contract (IDC) with Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is valued at up to $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The specific contract award referenced is a $107,600.33 delivery order under this larger IDC, with a completion date of October 25, 2023. The contract has a firm fixed price pricing type and does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $107.6k | 10/24/23 |